$23.59
0.21% yesterday
NYSE, Sep 04, 10:00 pm CET
ISIN
US0718131099
Symbol
BAX

Baxter International Stock price

$23.58
+1.14 5.08% 1M
-11.21 32.22% 6M
-5.58 19.14% YTD
-13.95 37.17% 1Y
-32.63 58.05% 3Y
-58.72 71.35% 5Y
-12.56 34.75% 10Y
+2.14 10.00% 20Y
NYSE, Closing price Thu, Sep 04 2025
+0.04 0.17%

Key metrics

Basic
Market capitalization
$12.1b
Enterprise Value
$19.9b
Net debt
$7.8b
Cash
$1.7b
Shares outstanding
513.5m
Valuation (TTM | estimate)
P/E
negative | 9.6
P/S
1.1 | 1.1
EV/Sales
1.8 | 1.7
EV/FCF
57.0
P/B
1.7
Dividends
DPS
$1.04
Yield 1Y | 5Y
4.4% | 1.7%
Growth 1Y | 5Y
-10.3% | 4.1%
Payout 1Y | 3Y
-81.9% | -380.7%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$10.9b | $11.4b
EBITDA
$781.0m | $2.5b
EBIT
$629.0m | $1.6b
Net Income
$-155.0m | $1.3b
Free Cash Flow
$349.0m
Growth (TTM | estimate)
Revenue
-27.4% | 7.4%
EBITDA
-46.0% | 129.7%
EBIT
-49.3% | 86.1%
Net Income
-106.3% | 295.1%
Free Cash Flow
-32.6%
Margin (TTM | estimate)
Gross
36.0%
EBITDA
7.2% | 21.9%
EBIT
5.8%
Net
-1.4% | 11.1%
Free Cash Flow
3.2%
Financial Health
Equity Ratio
27.0%
Return on Equity
-9.3%
ROCE
3.5%
ROIC
2.6%
Debt/Equity
1.3
More
EPS
$-0.3
FCF per Share
$0.7
Short interest
6.8%
Employees
38k
Rev per Employee
$280.0k
Show more

Is Baxter International a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Baxter International Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Baxter International forecast:

6x Buy
27%
14x Hold
64%
2x Sell
9%

Analyst Opinions

22 Analysts have issued a Baxter International forecast:

Buy
27%
Hold
64%
Sell
9%

Financial data from Baxter International

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
10,887 10,887
27% 27%
100%
- Direct Costs 6,967 6,967
27% 27%
64%
3,920 3,920
28% 28%
36%
- Selling and Administrative Expenses 2,656 2,656
21% 21%
24%
- Research and Development Expense 583 583
13% 13%
5%
781 781
46% 46%
7%
- Depreciation and Amortization 152 152
27% 27%
1%
EBIT (Operating Income) EBIT 629 629
49% 49%
6%
Net Profit -155 -155
106% 106%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Baxter International directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Baxter International Stock News

Negative
Forbes
9 days ago
Baxter stock (NYSE: BAX), a healthcare company, has seen its stock decline by 14% over the past month. This drop followed a disappointing earnings report where the company also reduced its full-year guidance, partly due to Hurricane Helene impacting one of its manufacturing facilities.
Neutral
The Motley Fool
about one month ago
Baxter (BAX) Q2 Revenue Rises 4%
Neutral
Seeking Alpha
about one month ago
Baxter International Inc. (NYSE:BAX ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather Knight - Executive Vice President & COO Joel T. Grade - Executive VP & CFO Conference Call Participants David Harrison Roman - Goldman Sachs Group, Inc., Research Division Lawr...
More Baxter International News

Company Profile

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Head office United States
CEO D. Shafer
Employees 38,000
Founded 1931
Website www.baxter.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today